| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Stenosis | 14 | 2020 | 58 | 2.970 |
Why?
|
| Stroke | 13 | 2019 | 585 | 1.780 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 13 | 2020 | 30 | 1.770 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2018 | 47 | 1.760 |
Why?
|
| Temporal Lobe | 3 | 2017 | 30 | 1.590 |
Why?
|
| Acoustic Stimulation | 4 | 2018 | 126 | 1.330 |
Why?
|
| Allostasis | 3 | 2017 | 12 | 1.260 |
Why?
|
| Military Personnel | 2 | 2018 | 92 | 1.130 |
Why?
|
| Blood Flow Velocity | 10 | 2019 | 77 | 1.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2011 | 46 | 1.010 |
Why?
|
| Cerebrovascular Circulation | 3 | 2019 | 93 | 0.840 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2013 | 41 | 0.810 |
Why?
|
| Heart Rate | 4 | 2017 | 335 | 0.810 |
Why?
|
| Ankle Brachial Index | 2 | 2011 | 39 | 0.750 |
Why?
|
| Baroreflex | 3 | 2017 | 84 | 0.740 |
Why?
|
| Brain | 6 | 2018 | 951 | 0.730 |
Why?
|
| Brain Ischemia | 3 | 2014 | 146 | 0.700 |
Why?
|
| Female | 35 | 2020 | 19959 | 0.690 |
Why?
|
| Humans | 51 | 2020 | 32005 | 0.690 |
Why?
|
| Male | 30 | 2020 | 19165 | 0.640 |
Why?
|
| Autonomic Nervous System | 2 | 2017 | 43 | 0.630 |
Why?
|
| Electroencephalography | 3 | 2017 | 73 | 0.620 |
Why?
|
| Carotid Arteries | 5 | 2020 | 99 | 0.610 |
Why?
|
| Middle Aged | 22 | 2020 | 11817 | 0.600 |
Why?
|
| Nerve Net | 1 | 2018 | 123 | 0.580 |
Why?
|
| Adult | 17 | 2020 | 9345 | 0.580 |
Why?
|
| Headache | 1 | 2017 | 75 | 0.570 |
Why?
|
| Migraine Disorders | 1 | 2017 | 67 | 0.550 |
Why?
|
| Videoconferencing | 2 | 2013 | 7 | 0.540 |
Why?
|
| Models, Theoretical | 1 | 2017 | 137 | 0.540 |
Why?
|
| Remote Consultation | 2 | 2013 | 12 | 0.530 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 13 | 0.530 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 1 | 2015 | 8 | 0.530 |
Why?
|
| Stress, Psychological | 2 | 2017 | 221 | 0.530 |
Why?
|
| Ischemic Attack, Transient | 3 | 2011 | 48 | 0.530 |
Why?
|
| Ultrasonography, Doppler, Color | 3 | 2006 | 19 | 0.520 |
Why?
|
| Dominance, Cerebral | 1 | 2015 | 10 | 0.510 |
Why?
|
| Electric Stimulation | 1 | 2015 | 104 | 0.490 |
Why?
|
| Hot Flashes | 1 | 2015 | 48 | 0.490 |
Why?
|
| Neural Pathways | 1 | 2015 | 94 | 0.490 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 54 | 0.490 |
Why?
|
| Intracranial Embolism | 2 | 2020 | 12 | 0.490 |
Why?
|
| Hemianopsia | 1 | 2014 | 6 | 0.470 |
Why?
|
| Citalopram | 1 | 2014 | 6 | 0.470 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 11 | 0.470 |
Why?
|
| Brain Chemistry | 1 | 2014 | 29 | 0.460 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 876 | 0.460 |
Why?
|
| Carotid Artery, Common | 2 | 2006 | 39 | 0.460 |
Why?
|
| Depression | 2 | 2015 | 444 | 0.460 |
Why?
|
| Aged | 21 | 2020 | 10301 | 0.450 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 42 | 0.450 |
Why?
|
| Hyperglycemia | 1 | 2014 | 84 | 0.450 |
Why?
|
| Registries | 3 | 2011 | 298 | 0.450 |
Why?
|
| Ocular Motility Disorders | 1 | 2013 | 3 | 0.440 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 163 | 0.430 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 3990 | 0.410 |
Why?
|
| Thailand | 4 | 2013 | 4 | 0.400 |
Why?
|
| Cerebrovascular Disorders | 4 | 2016 | 52 | 0.390 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2011 | 12 | 0.380 |
Why?
|
| Time Management | 1 | 2010 | 9 | 0.380 |
Why?
|
| Pilot Projects | 3 | 2017 | 545 | 0.370 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 158 | 0.360 |
Why?
|
| Chi-Square Distribution | 5 | 2013 | 297 | 0.350 |
Why?
|
| North Carolina | 5 | 2017 | 1514 | 0.340 |
Why?
|
| Blood Pressure | 4 | 2015 | 845 | 0.290 |
Why?
|
| Stents | 2 | 2008 | 177 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 918 | 0.290 |
Why?
|
| Hyperemia | 1 | 2006 | 11 | 0.280 |
Why?
|
| Sensitivity and Specificity | 6 | 2012 | 582 | 0.280 |
Why?
|
| Risk Factors | 9 | 2013 | 3876 | 0.270 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 45 | 0.270 |
Why?
|
| Prevalence | 5 | 2013 | 981 | 0.270 |
Why?
|
| Aging | 1 | 2012 | 946 | 0.260 |
Why?
|
| Accreditation | 2 | 2016 | 16 | 0.260 |
Why?
|
| Ophthalmic Artery | 2 | 2002 | 9 | 0.250 |
Why?
|
| Ambulatory Care Facilities | 2 | 2016 | 83 | 0.250 |
Why?
|
| Cerebral Angiography | 4 | 2011 | 60 | 0.250 |
Why?
|
| Adolescent | 4 | 2015 | 3539 | 0.240 |
Why?
|
| Medicare | 2 | 2016 | 206 | 0.230 |
Why?
|
| Logistic Models | 4 | 2011 | 781 | 0.230 |
Why?
|
| Angiography | 1 | 2003 | 80 | 0.210 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 3 | 0.210 |
Why?
|
| Early Diagnosis | 4 | 2011 | 62 | 0.210 |
Why?
|
| Area Under Curve | 2 | 2017 | 93 | 0.210 |
Why?
|
| Embolism, Air | 1 | 2002 | 5 | 0.210 |
Why?
|
| Jugular Veins | 1 | 2002 | 26 | 0.210 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2002 | 5 | 0.210 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 881 | 0.200 |
Why?
|
| Anterior Cerebral Artery | 1 | 2002 | 2 | 0.200 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 5 | 0.200 |
Why?
|
| Mass Screening | 3 | 2010 | 263 | 0.200 |
Why?
|
| Carotid Artery, Internal | 1 | 2002 | 32 | 0.200 |
Why?
|
| Retrospective Studies | 7 | 2020 | 3509 | 0.200 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 35 | 0.200 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 73 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2011 | 2282 | 0.190 |
Why?
|
| Therapeutic Touch | 2 | 2011 | 10 | 0.190 |
Why?
|
| Endocarditis | 1 | 2020 | 15 | 0.180 |
Why?
|
| Tunica Intima | 2 | 2012 | 57 | 0.180 |
Why?
|
| Ultrasonography | 2 | 2016 | 379 | 0.180 |
Why?
|
| Vascular Resistance | 1 | 2019 | 31 | 0.170 |
Why?
|
| Sex Factors | 2 | 2012 | 663 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 684 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 1328 | 0.160 |
Why?
|
| Interleukin-1 | 1 | 2017 | 33 | 0.150 |
Why?
|
| Vasopressins | 1 | 2017 | 17 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2017 | 30 | 0.150 |
Why?
|
| Epinephrine | 1 | 2017 | 40 | 0.150 |
Why?
|
| Endarterectomy, Carotid | 3 | 2008 | 30 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2018 | 178 | 0.150 |
Why?
|
| Young Adult | 3 | 2020 | 2636 | 0.150 |
Why?
|
| Norepinephrine | 1 | 2017 | 77 | 0.150 |
Why?
|
| Veterans | 1 | 2017 | 68 | 0.140 |
Why?
|
| Hemodynamics | 3 | 2002 | 155 | 0.140 |
Why?
|
| Disease Progression | 2 | 2017 | 594 | 0.140 |
Why?
|
| Forecasting | 1 | 2017 | 143 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 238 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2017 | 247 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2017 | 124 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2015 | 3306 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2017 | 244 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 762 | 0.140 |
Why?
|
| Angiotensin I | 1 | 2017 | 241 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2017 | 162 | 0.130 |
Why?
|
| Posture | 1 | 2015 | 55 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2014 | 898 | 0.130 |
Why?
|
| Neurophysiology | 1 | 2015 | 10 | 0.130 |
Why?
|
| Research Design | 1 | 2017 | 313 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2017 | 399 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2017 | 1817 | 0.120 |
Why?
|
| Menopause | 1 | 2015 | 95 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 56 | 0.120 |
Why?
|
| Reference Values | 2 | 2012 | 246 | 0.120 |
Why?
|
| Risk Assessment | 5 | 2011 | 1426 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2014 | 66 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 94 | 0.110 |
Why?
|
| Benchmarking | 1 | 2013 | 23 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2014 | 126 | 0.110 |
Why?
|
| Time Factors | 4 | 2013 | 2149 | 0.100 |
Why?
|
| Collateral Circulation | 2 | 2002 | 9 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 241 | 0.100 |
Why?
|
| Linear Models | 2 | 2003 | 447 | 0.100 |
Why?
|
| Atherosclerosis | 2 | 2016 | 766 | 0.100 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2020 | 19 | 0.100 |
Why?
|
| Cerebral Arteries | 2 | 2009 | 18 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2013 | 141 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 517 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 160 | 0.100 |
Why?
|
| Holistic Health | 1 | 2011 | 7 | 0.100 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2011 | 108 | 0.090 |
Why?
|
| Waiting Lists | 1 | 2010 | 34 | 0.090 |
Why?
|
| Pruritus | 1 | 2011 | 47 | 0.090 |
Why?
|
| Faculty, Nursing | 1 | 2010 | 1 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 77 | 0.090 |
Why?
|
| United States | 4 | 2016 | 3939 | 0.090 |
Why?
|
| Community Health Services | 1 | 2010 | 56 | 0.090 |
Why?
|
| Leadership | 1 | 2010 | 37 | 0.090 |
Why?
|
| Radiology | 1 | 2010 | 41 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 472 | 0.080 |
Why?
|
| Burnout, Professional | 1 | 2010 | 51 | 0.080 |
Why?
|
| HIV Infections | 1 | 2014 | 394 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 53 | 0.080 |
Why?
|
| Anxiety | 1 | 2010 | 191 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 172 | 0.080 |
Why?
|
| Transportation of Patients | 1 | 2008 | 26 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 271 | 0.080 |
Why?
|
| Patient Admission | 1 | 2008 | 60 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2010 | 227 | 0.080 |
Why?
|
| Angioplasty | 1 | 2008 | 34 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 1188 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 470 | 0.070 |
Why?
|
| Quinolines | 1 | 2007 | 21 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 401 | 0.070 |
Why?
|
| Heptanoic Acids | 1 | 2007 | 29 | 0.070 |
Why?
|
| Pyrroles | 1 | 2007 | 55 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 114 | 0.070 |
Why?
|
| Anticholesteremic Agents | 1 | 2007 | 39 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2007 | 53 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 353 | 0.070 |
Why?
|
| ROC Curve | 2 | 2009 | 164 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 178 | 0.070 |
Why?
|
| Cholesterol | 1 | 2007 | 252 | 0.070 |
Why?
|
| Ethnic Groups | 1 | 2008 | 476 | 0.060 |
Why?
|
| Expert Systems | 1 | 2004 | 4 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 5 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2004 | 72 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 32 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 53 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 78 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2006 | 1269 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 226 | 0.050 |
Why?
|
| Amobarbital | 1 | 2002 | 2 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2002 | 7 | 0.050 |
Why?
|
| Epilepsies, Partial | 1 | 2002 | 9 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 24 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 28 | 0.050 |
Why?
|
| Arm | 1 | 2002 | 35 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2002 | 48 | 0.050 |
Why?
|
| Contrast Media | 1 | 2002 | 138 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2002 | 463 | 0.050 |
Why?
|
| Child | 1 | 2006 | 2438 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 1497 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 291 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 163 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 33 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 54 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2014 | 108 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 510 | 0.030 |
Why?
|
| Workflow | 1 | 2013 | 21 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 355 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 63 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 70 | 0.030 |
Why?
|
| Software | 1 | 2013 | 123 | 0.030 |
Why?
|
| Mental Recall | 1 | 2010 | 51 | 0.020 |
Why?
|
| Telephone | 1 | 2010 | 59 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2011 | 93 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 73 | 0.020 |
Why?
|
| Motivation | 1 | 2010 | 112 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 293 | 0.020 |
Why?
|
| Health Behavior | 1 | 2010 | 232 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 225 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 753 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 240 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1128 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2007 | 525 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 276 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2004 | 3 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 11 | 0.010 |
Why?
|
| Software Design | 1 | 2004 | 6 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2004 | 26 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 86 | 0.010 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2004 | 21 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2004 | 27 | 0.010 |
Why?
|
| Thalamus | 1 | 2004 | 33 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 158 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 125 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 23 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 6 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2002 | 56 | 0.010 |
Why?
|
| Memory | 1 | 2002 | 190 | 0.010 |
Why?
|
| Motor Activity | 1 | 2002 | 325 | 0.010 |
Why?
|